J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 86 (2005), 2221-2229; DOI 10.1099/vir.0.81074-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Espert, L.
Right arrow Articles by Mechti, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espert, L.
Right arrow Articles by Mechti, N.
Agricola
Right arrow Articles by Espert, L.
Right arrow Articles by Mechti, N.
© 2005 Society for General Microbiology

Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1

Lucile Espert1,{dagger}, Geneviève Degols1,{dagger}, Yea-Lih Lin2, Thierry Vincent3, Monsef Benkirane2 and Nadir Mechti1

1 CNRS, UMR-5160, EFS, 240 avenue Emile Jeanbrau, 34094 Montpellier Cedex 5, France
2 Institut de Genetique Humaine, CNRS, UPR-1142, 141 rue de la Cardonille, 34396 Montpellier Cedex 5, France
3 Laboratoire d'Immunologie, Hôpital St-Eloi, 80 Avenue A. Fliche, 34295 Montpellier Cedex 5, France

Correspondence
Nadir Mechti
nadir.mechti{at}ibph.pharma.univ-montp1.fr

Interferons (IFNs) encode a family of secreted proteins that provide the front-line defence against viral infections. It was recently shown that ISG20, a new 3'->5' exoribonuclease member of the DEDD superfamily of exonucleases, represents a novel antiviral pathway in the mechanism of IFN action. In this report, it was shown that ISG20 expression is rapidly and strongly induced during human immunodeficiency virus type 1 (HIV-1) infection. In addition, it was demonstrated that the replication kinetics of an HIV-1-derived virus expressing the ISG20 protein (HIV-1NL4-3ISG20) was delayed in both CEM cells and peripheral blood mononuclear cells. No antiviral effect was observed in cells overexpressing a mutated ISG20 protein defective in exonuclease activity, suggesting that the antiviral effect was due to the exonuclease activity of ISG20. Paradoxically, despite the antiviral activity of ISG20 protein, virus rescue observed in HIV-1NL4-3ISG20-infected cells was not due to mutation or partial deletion of the ISG20 transgene, suggesting that the virus was able to counteract the cellular defences. In addition, HIV-1-induced apoptosis was significantly reduced in HIV-1NL4-3ISG20-infected cells suggesting that emergence of HIV-1NL4-3ISG20 was associated with the inhibition of HIV-1-induced apoptosis. Altogether, these data reflect the ineffectiveness of virus replication in cells overexpressing ISG20 and demonstrate that ISG20 represents a new factor in the IFN-mediated antiviral barrier against HIV-1.

{dagger}These authors contributed equally to this work.




This article has been cited by other articles:


Home page
J. Virol.Home page
B. P. Doehle, F. Hladik, J. P. McNevin, M. J. McElrath, and M. Gale Jr.
Human Immunodeficiency Virus Type 1 Mediates Global Disruption of Innate Antiviral Signaling and Immune Defenses within Infected Cells
J. Virol., October 15, 2009; 83(20): 10395 - 10405.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Greenwell-Wild, N. Vazquez, W. Jin, Z. Rangel, P. J. Munson, and S. M. Wahl
Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon
Blood, August 27, 2009; 114(9): 1864 - 1874.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Tan, W. Qiao, J. Wang, F. Xu, Y. Li, J. Zhou, Q. Chen, and Y. Geng
IFP35 Is Involved in the Antiviral Function of Interferon by Association with the Viral Tas Transactivator of Bovine Foamy Virus
J. Virol., May 1, 2008; 82(9): 4275 - 4283.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Peng, J. Zhu, Y. Hwangbo, L. Corey, and R. E. Bumgarner
Independent and Cooperative Antiviral Actions of Beta Interferon and Gamma Interferon against Herpes Simplex Virus Replication in Primary Human Fibroblasts
J. Virol., February 15, 2008; 82(4): 1934 - 1945.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Jiang, H. Guo, C. Xu, J. Chang, B. Gu, L. Wang, T. M. Block, and J.-T. Guo
Identification of Three Interferon-Inducible Cellular Enzymes That Inhibit the Replication of Hepatitis C Virus
J. Virol., February 15, 2008; 82(4): 1665 - 1678.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Zhang, C. W. Burke, K. D. Ryman, and W. B. Klimstra
Identification and Characterization of Interferon-Induced Proteins That Inhibit Alphavirus Replication
J. Virol., October 15, 2007; 81(20): 11246 - 11255.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. M. Wahl, T. Greenwell-Wild, and N. Vazquez
HIV accomplices and adversaries in macrophage infection
J. Leukoc. Biol., November 1, 2006; 80(5): 973 - 983.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Okumura, G. Lu, I. Pitha-Rowe, and P. M. Pitha
Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15
PNAS, January 31, 2006; 103(5): 1440 - 1445.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2005 by the Society for General Microbiology.